e-learning
resources
Vienna 2012
Sunday, 02.09.2012
COPD comorbidities II
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The prevalence of undiagnosed COPD and approaches to promote early COPD diagnosis in lung cancer population
J. Zhang, J.B. Zhou, X.F. Lin, Q. Wang, C. Bai, Q.Y. Hong (Shanghai, China)
Source:
Annual Congress 2012 - COPD comorbidities II
Session:
COPD comorbidities II
Session type:
Thematic Poster Session
Number:
556
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Zhang, J.B. Zhou, X.F. Lin, Q. Wang, C. Bai, Q.Y. Hong (Shanghai, China). The prevalence of undiagnosed COPD and approaches to promote early COPD diagnosis in lung cancer population. Eur Respir J 2012; 40: Suppl. 56, 556
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Related content which might interest you:
What is real prevalence of COPD in patients with lung cancer?
Source: Annual Congress 2008 - Comorbidities in COPD
Year: 2008
A clinical study of lung cancer cases with underlying COPD in relation to the COPD phenotype
Source: Annual Congress 2010 - Regulation of airway hyperresponsiveness and bronchodilators
Year: 2010
COPD and lung cancer incidence in never smokers
Source: International Congress 2019 – Asthma and COPD comorbidities
Year: 2019
Prevalence and clinical characteristics of lung cancer with COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 321s
Year: 2005
Prevalence and burden of bronchiectasis in a lung cancer screening program
Source: International Congress 2019 – Airway infection in COPD
Year: 2019
Incidence of lung cancer among COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 494s
Year: 2005
COPD, asthma, and lung cancer patients
Source: International Congress 2016 – ME13 Smoking cessation in difficult population groups
Year: 2016
COPD prevalence is increased in lung cancer, independent of age, sex and smoking history
Source: Eur Respir J 2009; 33: 380-386
Year: 2009
Discharge support and readmission of older patients with lung cancer
Source: Annual Congress 2007 - Nurses' involvement in the follow-up of patients with COPD and lung cancer
Year: 2007
Spirometry and under-diagnosis of COPD in a lung cancer screening cohort
Source: Virtual Congress 2021 – New clinical and biological developments in lung cancer
Year: 2021
COPD screening and risk factor frequency identification study
Source: Annual Congress 2013 –Disease control and quality of life in airway diseases
Year: 2013
COPD in patients with lung cancer and smoking
Source: Eur Respir J 2005; 26: Suppl. 49, 519s
Year: 2005
The impact of overweight and obesity on acute exacerbations of COPD - subgroup analysis of the Taiwan obstructive lung disease cohort
Source: International Congress 2017 – Primary care pulmonary rehabilitation, multimorbidity and organisation of care
Year: 2017
Cardiovascular comorbidities prevails in the early stages of COPD irrespective of predominant airway or emphysema phenotype
Source: Annual Congress 2013 –COPD treatment
Year: 2013
The association between lung function in adults and future burden of obstructive lung diseases in a long-term follow-up
Source: Virtual Congress 2020 – Diagnosis and management of airways disease in primary care
Year: 2020
The decrease of nutritional status and increasing of the risk of osteoporotic fractures in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013
Management of concomitant COPD in patients with lung cancer
Source: International Congress 2018 – Lung cancer: personalised medicine
Year: 2018
Clinical feature of elderly patients with lung cancer and COPD
Source: Annual Congress 2009 - Clinical aspects and epidemiology in lung cancer
Year: 2009
Will the population ²at risk for COPD² develop COPD?
Source: Eur Respir J 2005; 26: Suppl. 49, 218s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept